Xeris Pharmaceuticals
XERS
#6219
Rank
A$1.05 B
Marketcap
$6.75
Share price
0.70%
Change (1 day)
151.94%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2024 (TTM): -A$39.4 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are A$0.20 Billion. , an increase over its 2023 earnings that were of -A$57.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$41.7 Million-27.85%
2023 -A$57.8 Million-54.31%
2022 -A$0.13 Billion-30.11%
2021 -A$0.19 Billion43.37%
2020 -A$0.13 Billion-32.21%
2019 -A$0.19 Billion106.61%
2018 -A$90.14 Million116.69%
2017 -A$41.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 436.82%๐Ÿ‡บ๐Ÿ‡ธ USA